Share this

References:

  1. Food and Drug Administration. Center for Biologics Evaluation and Research (CBER). CBER clinical review of studies submitted in support of
    licensure of ProQuad. https:// www.fda.gov/media/165978/download. Accessed July 2026.
  2. Shinefield H, Black S, Digilio L, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect
    Dis J. 2005;24(8):665-669.
  3. ProQuad Summary of Product Characteristics.
  4. Jacobsen SJ, Ackerson BK, Sy LS, et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care
    setting. Vaccine. 2009;27(34):4656-4661.

AE-QDX-00012 | Exp: 25 July 2028